Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.

International journal of geriatric psychiatry - 1 Sept 1998

MacGowan S H, Wilcock G K, Scott M

Abstract excerpt

BACKGROUND: Anticholinesterase therapies offer modest benefit to subgroups of AD sufferers. However, there has previously been no way of predicting which patients will respond to any of the drugs. OBJECTIVE: To discover if gender and/or apolipoprotein E genotype can be used as predictors of response in the clinical setting. DESIGN: 107 patients from the Bristol Memory Disorders Clinic took part in a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoproteins E
Share to Cholinesterase Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Double-Blind Method

Share to Genotype

Share to Sex Characteristics

Share to Time Factors

Source

Identifiers

PMID: 9777427
DOI: 10.1002/(sici)1099-1166(199809)13:9<625::aid-gps835>3.0.co;2-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.PMID 9777427Read ↗

Apolipoprotein E genotype and gender influence response to tacrine therapy.Semantic proximity Read ↗

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.Semantic proximity Read ↗

The apolipoprotein E epsilon4 allele and the response to tacrine therapy in Alzheimer's disease.Semantic proximity Read ↗

Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's disease.Semantic proximity Read ↗

Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.Semantic proximity Read ↗

Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's diseaseSemantic proximity Read ↗

Response to rivastigmine transdermal patch or memantine plus rivastigmine patch is affected by apolipoprotein E genotype in Alzheimer patients.Semantic proximity Read ↗

Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease.Semantic proximity Read ↗

Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.Semantic proximity Read ↗

Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study.Semantic proximity Read ↗

APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.Semantic proximity Read ↗

Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.